Trial · NCT07904078
Demographic Data Collection in Healthcare
NCT07904078, Not applicable, Recruiting, Pacific Institute for Research and Evaluation
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Demographic Data Collection in Healthcare. Trials, record NCT07904078. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07904078
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Demographic Data Collection in Healthcare
- NCT number
- NCT07904078
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 1,320 participants, estimated
- Lead sponsor
- Pacific Institute for Research and Evaluation
- Conditions
- Implementation Strategies
- Interventions
- Training, Implementation Strategy 1, Implementation Strategy 2
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adoption - Electronic Health Records (EHR) | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | Data on SOGI will be extracted from EHRs at participating PHOs by NMHealth. This data will be reviewed to calculate the percentage of patients with SOGI data collection recorded out of the total patients seen over the two months prior to the assessment. This is the outcome for which the SMART is powered. |
| Secondary | Organizational Readiness to Change Assessment (ORCA) | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | The ORCA tool measures organizational readiness to implement evidence-based practices in clinical settings. We will use five subscales of this 77-item measure to focus data collection and reduce burdens on participants: 1) the staff organizational culture subscale, 2) the leadership subscale on formal leadership and team building, 3) the subscale on evaluation of goal setting and tracking and communicating performance, 4) the readiness for change subscale on the attitudes of opinion leaders for practice change, and 5) the subscale general resources. Data for this measure will be collected during each phased assessment of the SMART. |
| Secondary | Lesbian, Gay, Bisexual, and Transgender Development of Clinical Skills Scale (LGBT-DOCSS) | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | This 18-item measure will assess PHO personnel's 1) clinical preparedness (e.g., LGBT training and clinical experiences), 2) attitudinal awareness (e.g., LGBT explicit bias and prejudice), and 3) basic knowledge (e.g., LGBT health and mental health disparities). The LGBT-DOCSS will be used with the ICS to examine innovation-specific capacity. Data for this measure will be collected during each phased assessment of the SMART. While the development of clinical skills is not a specific focus of the intervention, clinical skills measures by the LGBT-DOCSS may be an important confounding variable to capture. |
| Secondary | Implementation Climate Scale (ICS) | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | This 18-item measure will assess the extent to which a PHO prioritizes and values the successful implementation of evidence-based practices. The ICS will be used with the LGBT-DOCSS to examine innovation-specific capacity. Data for this measure will be collected during each phased assessment of the SMART. |
| Secondary | Acceptability, Feasibility, and Appropriateness of Intervention Measure | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | This 12-item measure will be administered to PHO personnel across all sites annually to assess the extent to which implementation strategies are appealing, liked, and welcomed in their setting (acceptability); fitting, suitable, and applicable in their setting (appropriateness); and possible and doable in their setting (feasible). Data for this measure will be collected during each phased assessment of the SMART. |
| Secondary | Attitudes toward Lesbians and Gay Men Scale (ATLG) | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | The ATLG Scale is a brief, 20-item measure of heterosexual peoples' attitudes toward gay men and lesbians. This scale and the BIAS-A, ATTI, and EBPAS will be used to examine motivation. Data for this measure will be collected during each phased assessment of the SMART. |
| Secondary | Bisexualities: Indiana Attitudes Scale-Abridged (BIAS-A) | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | This scale is used to measure associations between biphobia and sexual identity; two 5-item subscales measure attitudes toward bisexual men and attitudes toward bisexual women. This scale and the ATLG, ATTI, and EBPAS will be used to examine motivation. Data for this measure will be collected during each phased assessment of the SMART. |
| Secondary | Attitudes toward Transgender Individuals Scale (ATTI) | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | The ATTI Scale is a 20-item measure of attitudes toward transgender individuals, including transgender-related stigma among members of the general population. This scale and the BIAS-A, ATLG, and EBPAS will be used to examine motivation. Data for this measure will be collected during each phased assessment of the SMART. |
| Secondary | Evidence-Based Practice Attitude Scale (EBPAS) | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | The EBPAS is a 15-item tool developed to assess willingness to adopt an innovation given their attitudes toward using evidence-based practices. The measure has high internal consistency reliability (α=0.79). This scale and the BIAS-A, ATLG, and ATTI will be used to examine motivation. Data for this measure will be collected during each phased assessment of the SMART. |
| Secondary | Consumer Assessment of Healthcare Providers and Systems Clinician and Group Adult Survey (CG-CAHPS), v.3 | Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. | The 31-item CG-CAHPS, v.3, examines patient experiences with healthcare providers. Measures focus on getting timely appointments, care, and information; how well providers communicate and use the information to coordinate patient care; helpful, courteous, and respectful office staff; and patient rating of the provider. Its internal consistency estimates range from .77 to .89 across subscales, indicating acceptable to good reliability. Because of its acceptable psychometric properties at the individual and practice site levels, data for this measure will be collected during each phased assessment of the SMART. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07904078
GET https://conductscience.org/api/trials/v1/NCT07904078/registered